Castle Biosciences (CSTL) vs YD Bio (YDES)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Castle Biosciences (CSTL) has outperformed YD Bio (YDES) over the past year, gaining 42.9% versus a loss of 66.1%. Castle Biosciences is the larger company by market cap ($1.03 billion vs $410.1 million), about 2.5 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CSTL | YDES |
|---|---|---|
| Share price | $33.71 | $5.79 |
| Market cap | $1.03B | $410.11M |
| 1-day change | +2.15% | -1.53% |
| YTD return | -13.34% | -52.50% |
| 1-year return | +42.90% | -66.06% |
| 5-year return | -46.98% | — |
| EPS (TTM) | $-0.64 | $-0.04 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $44.28 | $22.00 |
| 52-week low | $17.72 | $1.70 |
| Distance from 52-week high | -23.87% | -73.68% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +33.82% | — |
| Average volume | 402.90K | 284.92K |
| Shares outstanding | 30.55M | 70.83M |
| Employees | 1,002 | 13 |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Castle Biosciences is about 2.5 times larger than YD Bio by market value ($1.03B vs $410.11M).
- CSTL has outperformed YDES by 109.0 percentage points over the past year.
About Castle Biosciences
CSTL stock →Castle Biosciences, Inc., a molecular diagnostics company, provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), atopic dermatitis (AD), and uveal melanoma. The company offers DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test that predicts the likelihood of a positive sentinel lymph node and the risk of metastasis for patients with invasive cutaneous melanoma; TissueCypher, a risk stratification spatialomics test to predict future development of high-grade dysplasia and/or esophageal cancer in patients with non-dysplastic, indefinite dysplasia, and low-grade dysplasia BE; AdvanceAD-Tx, a non-invasive GEP test which is designed to guide systemic treatment selection for patients aged 12 years and older with moderateto-severe AD; DecisionDx-SCC, a GEP test for cutaneous squamous cell carcinoma; and MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions.
Health Care · Medical Specialities · 1,002 employees
About YD Bio
YDES stock →YD Bio Limited, a biopharmaceutical company, focuses on regulated diagnostics, life science clinical services, and healthcare product commercialization in the United States and Taiwan. The company offers eye disease treatment products, 3D LensMate Artificial Tears, a natural tear-mimicking lubricant that moisturizes the eyes and relieves dry eye symptoms; 3D LensMate Eye Drops, an ophthalmic solution to alleviate symptoms of dry eye syndrome, including irritation, foreign body sensation, and eye fatigue; and LSC Eye Drug/Injection, an injectable ophthalmic drug is being developed for the treatment of various retinal and macular disorders, such as age-related macular degeneration, macular edema, choroidal and subretinal neovascularization, and neovascular glaucoma.
Health Care · Medical Specialities · 13 employees
CSTL vs YDES FAQ
Which is bigger, Castle Biosciences or YD Bio?
Castle Biosciences (CSTL) is larger, with a market capitalization of $1.03B compared with $410.11M for YD Bio (YDES).
Which stock has performed better over the past year, CSTL or YDES?
CSTL returned +42.90% over the past 12 months, compared with -66.06% for YDES (price return, excluding dividends). Past performance does not predict future results.
Are Castle Biosciences and YD Bio in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.